Krista Drobac shared her expertise with Fierce Healthcare on the importance of telehealth prescribing flexibilities.

She shared, “As we go to Congress and ask for intervention to extend the DEA flexibilities, questions arise about which Scheduled drugs should be accessible during the extension. Trying to decide which patients of those with ADHD, narcolepsy, cancer, pain, addiction, depression or anxiety should have to go to the office vs use telehealth is the crux of the issue. This is why we need a two-year extension. Threading the needle on access vs. prevention of diversion hasn’t been done yet. As a health care person, I want all people to have access, but law enforcement feels differently. We need to find the balance.”